Biotechnology Finance and Commercialisation
|Course code BIOL3220||Units 10||Level 3000||Faculty of Science and Information TechnologySchool of Environmental and Life Sciences|
Introduces students to the commercial and economic environment in which Australian biotechnology industries operate. Students will develop analytical skills to assess the commercial potential of biotechnology innovations, and an understanding of business models for biotechnology companies. Basic economic, business and finance concepts will be introduced. Students will learn to interpret prospectuses, company balance sheets and reports, and analysts' reports. Lectures will introduce the critical issues involved in successful commercialisation of biotechnology. The class will operate as a group of analysts to assess and rank a selection of listed Australian biotech companies based on their technology, products, management and investment potential.
Not available in 2014
|Previously offered in 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004|
|Objectives||On successful completion of this course, students will:|
1. understand how the broader economy and financial markets impact on the biotechnology sector.
2. be able to interpret prospectuses, company balance sheets and reports, and biotechnology analyst reports.
3. understand the steps critical to the commercialisation of biotechnology: innovation, R & D, intellectual property protection, product testing and licencing, raising and allocating capital, taxation.
4. have developed critical and analytical skills to evaluate the technological and commercial potential of biotechnology innovations and products.
5. have an overview of the major Australian biotechnology companies, and the future direction of biotechnological innovation in Australia.
|Content||1. Introduction to economics and financial markets|
2. Prospectuses, company reports and balance sheets, biotechnology analyst reports
3. Financing biotech companies and projects: raising and allocating capital - seed and venture capital, debt and equity
4. Valuation of biotech companies and product pipelines using cash flow models
5. Intellectual property protection and its relationship to profitability
6. Impacts of the tax system on the commercialisation of biotechnology
7. Biotechnology investment growth areas: genomics, transgenics, pharmaceuticals/diagnostics, vaccines
8. Biotechnology business models and management
9. Developing a biotechnology business plan
10. Entrepreneurship in biotechnology
|Assumed Knowledge||Completion of 1000 and 2000 level biotechnology courses is assumed. No prior enrolment in finance courses is expected.|
|Modes of Delivery||Internal Mode|
|Contact Hours||Lecture: for 3 hour(s) per Week for 5 weeks|
Tutorial: for 3 hour(s) per Week for 5 weeks